Notable Analyst Rating Changes 4/2: VOD, CHL, AZN Upgraded; UST, CROX, DKS Downgraded
More News related to AZN
- Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013
- U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
- AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured
- AstraZeneca (AZN) Submits NDA to U.S. FDA for Ticagrelor
- AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
More News related to CHL
- IR Magazine Announces the Hong Kong and Taiwan Conference & Awards 2009 Nominees Shortlist
- The Hong Kong Institute of Directors Announces Winners of Directors Of The Year Awards 2009
- Morgan Stanley Upgrades CHU to Overweight, Downgrades CHL, CHA to Equal Weight
- China Mobile Selects mInfo as SNS Mobile Search and Ad Partner
- IRG Technology, Media and Telecoms Weekly China Market Review
More News related to CROX
- Independent Research Firm Murphy Analytics Announces Initiation of Coverage on Crocs, Inc.
- Standpoint Research Downgraded Deckers Outdoor (DECK) to Hold
- Standpoint Research Initiates Coverage on Crocs (CROX) with a Buy
- Unusual 11 Mid-Day Movers 11/06: CBBO, OPTT, GROW, MGA Higher; GOK, OSTE, NHWK, OCLS Lower
- Morning Movers 11/06: ACLS, CVM, ZIOP, LPSN, CABL, ZGEN Higher; NHWK, GOK, CROX, CVI, RAIL, CSTR Lower
More News related to Special Reports
- After-Hours Movers 12/02: KTCC, PSS, SEAC, BAC Higher; SIGM, SNPS, ARO, JAS, VRTX Lower
- Trading Radar for 12/3: Marvell (MRVL), Toll Bros. (TOL), Del Monte (DLM), Smith & Wesson (SWHC) Report
- Unusual 11 Mid-Day Movers 12/02: ABCW, BIOF, GRH, STEM Higher; HEB, HDY, BGP, CBAK Lower
- Notable ETF Movers 12/2: GDX, TUR Up; UNG, USO, THD Down
- Notable Analyst Rating Changes 12/2: AMR/UAUA, RFMD, STI, SAY, KBH, BBT Upgraded; STZ, MTL, BWP, POM Downgraded
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Bear Stearns upgrades Vodafone (NYSE: VOD) from Peer Perform to Outperform.
Deutsche Bank upgrades China Mobile (NYSE: CHL) to Buy and raises its price target 35% to HK$143.20.
Citi upgrades AstraZeneca (NYSE: AZN) from Hold to Buy. Price target $46.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Goldman Sachs downgrades UST Inc. (NYSE: UST) from Buy to Neutral.
JP Morgan downgrades Crocs (Nasdaq: CROX) from Overweight to Neutral.
UBS downgrades Dick's Sporting Goods (NYSE: DKS) from Buy to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Morgan Keegan resumes coverage on XTO Energy (NYSE: XTO) with an Outperform.
Goldman Sachs initiates coverage on Philip Morris International (NYSE: PM) with a Buy rating and $60 price target.
UBS initiates coverage on Enbridge (NYSE: ENB) with a Buy rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.19
-0.45Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
